The Role of Gene Editing in Neurodegenerative Diseases

Cell Transplantation
Hueng-Chuen FanHorng-Jyh Harn

Abstract

Neurodegenerative diseases (NDs), at least including Alzheimer's, Huntington's, and Parkinson's diseases, have become the most dreaded maladies because there are no precise diagnostic tools or definite treatments for these debilitating diseases. The increased prevalence and a substantial impact on the social-economic and medical care of NDs propel governments to develop policies to counteract the impact. Although the etiologies of NDs are still unknown, growing evidence suggests that genetic, cellular, and circuit alternations may cause the generation of abnormal misfolded proteins, which uncontrolledly accumulate to damage and eventually overwhelm the protein-disposal mechanisms of these neurons, leading to a common pathological feature of NDs. If the functions and the connectivity can be restored, alterations and accumulated damages may improve. The gene-editing tools including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeats-associated nucleases (CRISPR/CAS) have emerged as a novel tool not only for generating specific ND animal models for interrogating the mechanisms and screening potential drugs against NDs but also for the...Continue Reading

References

May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·Q LiuC F Barbas
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·D A WahA K Aggarwal
Mar 14, 2000·Archives of Neurology·M MenkenJ F Toole
Aug 15, 2000·Annual Review of Biophysics and Biomolecular Structure·S A WolfeC O Pabo
Feb 17, 2001·Current Opinion in Structural Biology·J H LaityP E Wright
Jul 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·K M VasquezJ H Wilson
Feb 1, 2002·Nature Biotechnology·Roger R Beerli, Carlos F Barbas
Apr 16, 2002·Molecular Microbiology·Ruud JansenLeo M Schouls
Apr 25, 2002·Nature Reviews. Genetics·Daniel St Johnston
May 4, 2002·Nature Reviews. Genetics·Erik M Jorgensen, Susan E Mango
May 4, 2002·Nature Reviews. Neuroscience·Ferdinando Rossi, Elena Cattaneo
Nov 2, 2002·Neuroepidemiology·H KimuraT Kato
May 2, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Irene LitvanUNKNOWN Movement Disorders Society Scientific Issues Committee
Aug 5, 2003·Molecular and Cellular Biology·Kai RothkammMarkus Löbrich
Mar 16, 2005·Archives of Neurology·Zhen-Xin ZhangHui Li
Mar 29, 2005·Journal of Molecular Evolution·Francisco J M MojicaElena Soria
Apr 1, 2005·Nucleic Acids Research·Shibin QiuTerran Lane
Apr 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Scott Q HarperBeverly L Davidson
Oct 28, 2005·Nucleic Acids Research·Sundar DuraiSrinivasan Chandrasegaran
Jan 13, 2006·Journal of Plant Physiology·Sebastian SchornackThomas Lahaye
Feb 3, 2006·Genetics·Kelly BeumerDana Carroll
May 23, 2006·Lancet Neurology·Lonneke M L de Lau, Monique M B Breteler
Aug 10, 2006·Annual Review of Genetics·Claire Wyman, Roland Kanaar
Oct 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jason MortonDana Carroll
Mar 24, 2007·Science·Rodolphe BarrangouPhilippe Horvath
Jul 3, 2007·Nature Biotechnology·Jeffrey C MillerEdward J Rebar
Oct 4, 2007·Human Molecular Genetics·Bobby Thomas, M Flint Beal
May 1, 2008·Nature Methods·Cherie L RamirezJ Keith Joung
May 27, 2008·Nature Biotechnology·Yannick DoyonSharon L Amacher
May 27, 2008·Nature Biotechnology·Xiangdong MengScot A Wolfe
Aug 16, 2008·Science·Stan J J BrounsJohn van der Oost

❮ Previous
Next ❯

Citations

Jul 25, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Deepa Dash, Tiago A Mestre

❮ Previous
Next ❯

Methods Mentioned

BETA
stable gene
gene knockout
protein folding
one-hybrid
transgenic

Software Mentioned

CoDA
OPEN

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

Related Papers

Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Xiubin He, Feng Gu
Trends in Plant Science
Jorge Lozano-Juste, Sean R Cutler
Transgenic Research
Milan Kumar SamantaSrimonta Gayen
Current Opinion in Pharmacology
Claudio MussolinoToni Cathomen
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Lindsay A M ReinNelson J Chao
© 2022 Meta ULC. All rights reserved